Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)—Rationale and design-Reference-Cited by-同舟云学术

Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)—Rationale and design

Published:2014-09 Issue:3 Volume:64 Page:236-239
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Watanabe Tetsu,Miyamoto Takuya,Miyasita Takehiko,Shishido Tetsuro,Arimoto Takanori,Takahashi Hiroki,Nishiyama Satoshi,Hirono Osamu,Matsui Motoyuki,Sugawara Shigeo,Ikeno Eiichiro,Miyawaki Hiroshi,Akira Fukao,Kubota Isao

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N Engl J Med,2008

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators;Sacks;N Engl J Med,1996

4. Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS);Streja;Am J Cardiol,2002

5. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT;Journal of Clinical Lipidology;2022-07

2. Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides;Expert Opinion on Drug Safety;2021-09-07

3. Does the STRENGTH study confirm or disprove previous evidence on the role of n-3 polyunsaturated fatty acids in the prevention of cardiovascular events?;G ITAL CARDIOL;2021

4. A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins;Journal of Cardiology;2017-12

5. Potential benefits of eicosapentaenoic acid on atherosclerotic plaques;Vascular Pharmacology;2017-04